Literature DB >> 23506999

Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.

Matthew T Sutherland1, Allison J Carroll, Betty Jo Salmeron, Thomas J Ross, L Elliot Hong, Elliot A Stein.   

Abstract

BACKGROUND: Although the amygdala and insula are regarded as critical neural substrates perpetuating cigarette smoking, little is known about their circuit-level interactions with interconnected regions during nicotine withdrawal or following pharmacotherapy administration. To elucidate neurocircuitry associated with early smoking abstinence, we examined the impact of varenicline and nicotine, two modestly efficacious pharmacologic cessation aids, on amygdala- and insula-centered circuits using resting-state functional connectivity (rsFC).
METHODS: In a functional magnetic resonance imaging study employing a two-drug, placebo-controlled design, 24 overnight-abstinent smokers and 20 nonsmokers underwent ∼17 days of varenicline and placebo pill administration and were scanned, on different days under each condition, wearing a transdermal nicotine or placebo patch. We examined the impact of varenicline and nicotine (both alone and in combination) on amygdala- and insula-centered rsFC using seed-based assessments.
RESULTS: Beginning with a functionally defined amygdala seed, we observed that rsFC strength in an amygdala-insula circuit was down-regulated by varenicline and nicotine in abstinent smokers. Using this identified insula region as a new seed, both drugs similarly decreased rsFC between the insula and constituents of the canonical default-mode network (posterior cingulate cortex, ventromedial/dorsomedial prefrontal cortex, parahippocampus). Drug-induced rsFC modulations were critically linked with nicotine withdrawal, as similar effects were not detected in nonsmokers.
CONCLUSIONS: These results suggest that nicotine withdrawal is associated with elevated amygdala-insula and insula-default-mode network interactions. As these potentiated interactions were down-regulated by two pharmacotherapies, this effect may be a characteristic shared by pharmacologic agents promoting smoking cessation. Decreased rsFC in these circuits may contribute to amelioration of subjective withdrawal symptoms.
Copyright © 2013 Society of Biological Psychiatry. All rights reserved.

Entities:  

Keywords:  Amygdala; insula; nicotine; resting-state functional connectivity; varenicline; withdrawal

Mesh:

Substances:

Year:  2013        PMID: 23506999      PMCID: PMC3775982          DOI: 10.1016/j.biopsych.2013.01.035

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  64 in total

1.  Dissociable intrinsic connectivity networks for salience processing and executive control.

Authors:  William W Seeley; Vinod Menon; Alan F Schatzberg; Jennifer Keller; Gary H Glover; Heather Kenna; Allan L Reiss; Michael D Greicius
Journal:  J Neurosci       Date:  2007-02-28       Impact factor: 6.167

2.  Damage to the insula disrupts addiction to cigarette smoking.

Authors:  Nasir H Naqvi; David Rudrauf; Hanna Damasio; Antoine Bechara
Journal:  Science       Date:  2007-01-26       Impact factor: 47.728

Review 3.  Effects of abstinence from tobacco: valid symptoms and time course.

Authors:  John R Hughes
Journal:  Nicotine Tob Res       Date:  2007-03       Impact factor: 4.244

4.  A component based noise correction method (CompCor) for BOLD and perfusion based fMRI.

Authors:  Yashar Behzadi; Khaled Restom; Joy Liau; Thomas T Liu
Journal:  Neuroimage       Date:  2007-05-03       Impact factor: 6.556

5.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

6.  Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Authors:  David Gonzales; Stephen I Rennard; Mitchell Nides; Cheryl Oncken; Salomon Azoulay; Clare B Billing; Eric J Watsky; Jason Gong; Kathryn E Williams; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

7.  Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.

Authors:  Hélène M Faessel; Megan A Gibbs; David J Clark; Kevin Rohrbacher; Marilyn Stolar; Aaron H Burstein
Journal:  J Clin Pharmacol       Date:  2006-12       Impact factor: 3.126

8.  Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Authors:  H Rollema; L K Chambers; J W Coe; J Glowa; R S Hurst; L A Lebel; Y Lu; R S Mansbach; R J Mather; C C Rovetti; S B Sands; E Schaeffer; D W Schulz; F D Tingley; K E Williams
Journal:  Neuropharmacology       Date:  2006-12-08       Impact factor: 5.250

Review 9.  Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

Authors:  Hans Rollema; Jotham W Coe; Leslie K Chambers; Raymond S Hurst; Stephen M Stahl; Kathryn E Williams
Journal:  Trends Pharmacol Sci       Date:  2007-06-18       Impact factor: 14.819

10.  Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network.

Authors:  Britta Hahn; Thomas J Ross; Yihong Yang; Insook Kim; Marilyn A Huestis; Elliot A Stein
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

View more
  65 in total

1.  Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.

Authors:  Elise Lesage; Sarah E Aronson; Matthew T Sutherland; Thomas J Ross; Betty Jo Salmeron; Elliot A Stein
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

2.  Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies.

Authors:  Matthew T Sutherland; Kimberly L Ray; Michael C Riedel; Julio A Yanes; Elliot A Stein; Angela R Laird
Journal:  Biol Psychiatry       Date:  2015-01-07       Impact factor: 13.382

3.  Implications of insular cortex laterality for treatment of nicotine addiction.

Authors:  Amir Abdolahi; Geoffrey C Williams; Edwin van Wijngaarden
Journal:  Drug Alcohol Depend       Date:  2019-06-07       Impact factor: 4.492

4.  Nicotinic modulation of salience network connectivity and centrality in schizophrenia.

Authors:  Jason Smucny; Korey P Wylie; Eugene Kronberg; Kristina T Legget; Jason R Tregellas
Journal:  J Psychiatr Res       Date:  2017-02-03       Impact factor: 4.791

5.  Working memory-related neural activity predicts future smoking relapse.

Authors:  James Loughead; E Paul Wileyto; Kosha Ruparel; Mary Falcone; Ryan Hopson; Ruben Gur; Caryn Lerman
Journal:  Neuropsychopharmacology       Date:  2014-12-03       Impact factor: 7.853

6.  Insula-Dorsal Anterior Cingulate Cortex Coupling is Associated with Enhanced Brain Reactivity to Smoking Cues.

Authors:  Amy C Janes; Stacey Farmer; Alyssa L Peechatka; Blaise de B Frederick; Scott E Lukas
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

Review 7.  Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder.

Authors:  Matthew T Sutherland; Elliot A Stein
Journal:  Trends Mol Med       Date:  2018-02       Impact factor: 11.951

8.  Sex differences in resting state neural networks of nicotine-dependent cigarette smokers.

Authors:  Reagan R Wetherill; Kanchana Jagannathan; Joshua Shin; Teresa R Franklin
Journal:  Addict Behav       Date:  2014-01-24       Impact factor: 3.913

9.  Insula's functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving.

Authors:  Matthew T Sutherland; Allison J Carroll; Betty Jo Salmeron; Thomas J Ross; Elliot A Stein
Journal:  Psychopharmacology (Berl)       Date:  2013-02-28       Impact factor: 4.530

10.  Severity of dependence modulates smokers' functional connectivity in the reward circuit: a preliminary study.

Authors:  Zhujing Shen; Peiyu Huang; Wei Qian; Chao Wang; Hualiang Yu; Yihong Yang; Minming Zhang
Journal:  Psychopharmacology (Berl)       Date:  2016-03-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.